Neuromuscular Disorders

ADAPT analysis: efgartigimod for generalized myasthenia gravis 4:59
ADAPT analysis: efgartigimod for generalized myasthenia gravis
James F. Howard Jr. • 7 Apr 2021
Neurological diseases and obstructive sleeping apnea: patient evaluation and treatment 3:12
Neurological diseases and obstructive sleeping apnea: patient evaluation and treatment
Chantale Branson • 7 Apr 2021
Noninvasive ventilatory care in patients with breathing muscle weakness 3:27
Noninvasive ventilatory care in patients with breathing muscle weakness
John Bach • 6 Apr 2021
Management of COVID-19 respiratory complications to avoid intubation 3:40
Management of COVID-19 respiratory complications to avoid intubation
John Bach • 6 Apr 2021
Updates on a trial of SRP-9001 gene transfer therapy in Duchenne muscular dystrophy (DMD) 1:35
Updates on a trial of SRP-9001 gene transfer therapy in Duchenne muscular dystrophy (DMD)
Jerry Mendell • 6 Apr 2021
Gene therapy for Duchenne muscular dystrophy (DMD) 1:48
Gene therapy for Duchenne muscular dystrophy (DMD)
Jerry Mendell • 6 Apr 2021
AMX0035 in ALS: long-term survival analysis of the CENTAUR trial 3:40
AMX0035 in ALS: long-term survival analysis of the CENTAUR trial
Sabrina Paganoni • 15 Apr 2021
A new era in the discovery of ALS treatments 0:56
A new era in the discovery of ALS treatments
Sabrina Paganoni • 15 Apr 2021
The progress in gene therapy in neuromuscular diseases since its first clinical use 5:51
The progress in gene therapy in neuromuscular diseases since its first clinical use
Jerry Mendell • 6 Apr 2021
START trial long-term follow-up of onasemnogene abeparvovec in SMA 2:14
START trial long-term follow-up of onasemnogene abeparvovec in SMA
Jerry Mendell • 6 Apr 2021
Perspectives on gene therapy for neuromuscular disorders (NMD) 0:37
Perspectives on gene therapy for neuromuscular disorders (NMD)
Jerry Mendell • 6 Apr 2021
Synapse loss and cognitive decline in ALS: a common feature with Alzheimer’s? 1:07
Synapse loss and cognitive decline in ALS: a common feature with Alzheimer’s?
Tara Spires-Jones • 20 Mar 2018
The role of selective mitophagy in the pathogenesis of neurodegenerative diseases 1:29
The role of selective mitophagy in the pathogenesis of neurodegenerative diseases
Helene Plun-Favreau • 20 Mar 2018
The content of VJNeurology is intended for healthcare professionals